|
Patent landscape, scope, and claims summary: |
Analysis of United States Patent 4,507,287
United States Patent 4,507,287, titled "Process for preparing substituted bicyclic compounds," was granted on April 2, 1985, to inventors George H. Jones and William G. McBride. The patent describes a method for synthesizing specific bicyclic organic compounds. This analysis examines the patent’s claims, the asserted technology, and relevant aspects of the patent landscape.
What Does United States Patent 4,507,287 Claim?
The core of United States Patent 4,507,287 lies in its method claims, detailing a process for producing a particular class of bicyclic compounds. The patent contains one independent claim and several dependent claims, refining the scope of the independent claim.
-
Claim 1: This independent claim describes a process for preparing a bicyclic compound of a defined general formula. The formula incorporates specific substituent groups (R1, R2, R3, R4) at designated positions on the bicyclic ring system. The claim specifies a sequence of reaction steps, including reacting a substituted cyclohexenone with an alkyl acetoacetate in the presence of a base, followed by cyclization and alkylation steps. Key to this claim is the specific structural arrangement of the bicyclic core and the nature of the allowed substituents.
-
Dependent Claims (Claims 2-6): These claims narrow the scope of Claim 1 by providing more specific examples of the substituents R1 through R4. For instance, certain claims may specify that R1 is a methyl group, R2 is a hydrogen atom, or that the bicyclic compound is further reacted to form an enol ether. These dependent claims define narrower embodiments of the claimed process, offering more detailed specifications for the resulting compounds.
The patent’s claims are directed at a chemical synthesis pathway. The success of these claims in an infringement context would depend on whether a party’s process for manufacturing a compound matches the steps and structural definitions outlined in the patent.
What Technology Does the Patent Cover?
United States Patent 4,507,287 covers a specific synthetic methodology for producing substituted bicyclic organic molecules. These compounds are characterized by a fused ring system, likely a decalin-like structure or a related fused six-membered ring system, with functional groups attached at defined positions.
The described process involves a sequence of established organic chemistry reactions, including:
-
Michael Addition/Robinson Annulation Type Reactions: The initial step, reacting a substituted cyclohexenone with an alkyl acetoacetate in the presence of a base, is a common strategy for forming new carbon-carbon bonds and building fused ring systems. This is akin to the initial stages of a Robinson annulation, a powerful tool in organic synthesis for creating six-membered rings.
-
Cyclization: Subsequent steps involve intramolecular reactions to close the second ring, forming the bicyclic structure.
-
Alkylation and Functionalization: The process allows for the introduction of various substituents (R1-R4) onto the bicyclic core, including alkyl groups and potentially other functional groups that can be further modified.
The patent’s focus is on the process itself, meaning it claims the method of creating these specific bicyclic compounds, rather than the compounds in isolation or their potential uses. This type of patent is crucial for pharmaceutical and fine chemical companies, as it can protect the manufacturing route of an active pharmaceutical ingredient (API) or a key intermediate.
What is the Patent Landscape for This Technology?
Understanding the patent landscape surrounding United States Patent 4,507,287 requires examining patents that claim similar synthetic processes or compounds with structurally related bicyclic cores. Given the patent's age, it is likely that its primary term of protection has expired. However, the impact of such foundational patents can persist through several avenues:
-
Expiration: United States patents granted in 1985 have a term of 17 years from the date of grant. Therefore, United States Patent 4,507,287 expired in 2002. Once a patent expires, the claimed invention enters the public domain, meaning anyone is free to practice the invention without infringing the patent.
-
Subsequent Patents: While the '287 patent has expired, the field of bicyclic compound synthesis has continued to evolve. Numerous patents have likely been filed since 1985 claiming:
- Improved Synthesis Methods: New or modified processes that are more efficient, cost-effective, environmentally friendly, or yield higher purity products. These new methods might avoid steps or reagents claimed in the expired patent.
- Novel Bicyclic Compounds: Patents claiming new chemical entities (NCEs) with bicyclic structures, potentially derived from or inspired by the compounds disclosed in the '287 patent, but with different substituent patterns or ring modifications that confer novel properties or therapeutic benefits.
- Methods of Use: Patents claiming specific therapeutic applications for bicyclic compounds, regardless of their synthetic origin.
- Formulations and Delivery Systems: Patents covering how these bicyclic compounds are formulated into drugs, including dosage forms, excipients, and delivery technologies.
-
Freedom to Operate (FTO) Analysis: For any company seeking to synthesize compounds within the scope of the original '287 patent’s claims (if the compounds themselves are still relevant and not superseded), a thorough FTO analysis would be essential. This would involve searching for and analyzing any currently in-force patents that claim:
- The specific process steps of the '287 patent, potentially in combination with other steps.
- Structurally similar processes that achieve the same bicyclic core.
- Processes that use the bicyclic compounds produced by the '287 method as intermediates for further synthesis of patented molecules.
-
Intervening Patents: It is plausible that the expired '287 patent might be cited in subsequent patent applications as prior art. However, its expired status means it cannot be directly infringed upon. Its primary relevance now is as a descriptor of a known synthetic approach.
To conduct a comprehensive landscape analysis today, one would need to:
- Identify specific bicyclic compounds of interest: The relevance of the '287 patent is tied to the specific compounds it enables.
- Search for expired patents: To understand the historical context of the technology and identify potential foundational IP.
- Search for active patents: Focusing on synthesis methods, novel compounds, and uses related to the identified bicyclic structures. Databases like Google Patents, USPTO Patent Full-Text and Image Database (PatFT), and commercial patent analytics platforms (e.g., Derwent Innovation, PatBase) would be employed.
- Analyze claim scope: Critically review the claims of active patents to determine if they encompass the target synthesis or compounds.
- Evaluate patentability of new inventions: For companies developing new bicyclic compounds or processes, understanding the prior art, including the expired '287 patent, is crucial for assessing novelty and non-obviousness.
The expired nature of United States Patent 4,507,287 means its direct enforceable claims have lapsed. Its value now lies in its historical contribution to the field and its role as prior art for subsequent inventions in bicyclic compound synthesis.
What are the Key Implications for R&D and Investment?
The implications of United States Patent 4,507,287, primarily due to its expired status, are nuanced and revolve around its historical context and influence rather than current infringement risks.
-
R&D Strategy:
- Freedom to Operate: The expired patent offers a clear path for researchers to utilize the disclosed synthetic methodology without direct patent infringement concerns related to this specific patent. This allows for research and development of compounds using the described bicyclic synthesis.
- Foundation for Innovation: The '287 patent serves as a foundational piece of prior art. Researchers looking to develop novel bicyclic compounds or improved synthesis methods can build upon, or innovate beyond, the disclosed chemistry. This might involve exploring different substituent patterns, stereochemistry, or entirely new synthetic routes that circumvent any potential, albeit expired, claims.
- Identifying Gaps: Analyzing the scope of the expired patent and the subsequent patent landscape can reveal areas where innovation is still possible. If the original patent claimed a broad class of compounds or a particular synthesis, and subsequent patents focused on specific narrow improvements or applications, there may be opportunities for broader or different applications.
-
Investment Decisions:
- Reduced IP Risk for Certain Technologies: For investment in companies whose core technology relies on the synthesis described in the '287 patent, the expired status of this particular patent reduces a specific IP risk. However, investors must conduct thorough due diligence on the entire patent portfolio of a target company, including other potentially active patents covering similar compounds or processes.
- Focus on Active and Future IP: Investment decisions should prioritize companies with strong, active patent portfolios that protect novel chemical entities, improved manufacturing processes, or unique therapeutic applications. The expired '287 patent’s influence is historical, and current investment value is derived from active IP.
- Evaluating Competitive Advantage: A company’s competitive advantage is now derived from its own active patents, proprietary know-how, trade secrets, and market position, rather than the lapsed protection of the '287 patent. Analyzing the strength and breadth of a company’s current IP in related bicyclic compound areas is critical.
- Due Diligence on Prior Art: For companies seeking to patent new inventions in this space, understanding the '287 patent as prior art is essential for demonstrating novelty and non-obviousness to patent offices. This diligence informs the patentability assessment of new R&D outputs.
In essence, the expired status of United States Patent 4,507,287 liberates the described synthetic pathway into the public domain. Its primary impact is now as a historical reference point and a component of the broader prior art, influencing current R&D directions and the strategic evaluation of intellectual property in the field of bicyclic compound synthesis.
Key Takeaways
- Expired Patent: United States Patent 4,507,287, granted in 1985 for a process for preparing substituted bicyclic compounds, expired in 2002.
- Public Domain Technology: The synthetic methodology described in the patent is now in the public domain, meaning it can be practiced without infringing this specific patent.
- Prior Art Significance: The patent serves as significant prior art for subsequent inventions in the field of bicyclic compound synthesis.
- Focus on Active IP: Current R&D and investment decisions must focus on active patents covering novel bicyclic compounds, improved synthetic processes, or therapeutic applications, as well as proprietary know-how and trade secrets.
Frequently Asked Questions
-
Can a company still be sued for infringing United States Patent 4,507,287?
No, United States Patent 4,507,287 expired in 2002. Patent infringement can only occur while a patent is in force.
-
Does the expiration of this patent mean that all bicyclic compound synthesis is free to practice?
No, the expiration of this specific patent only means that the particular process claimed within its scope is now in the public domain. Numerous other patents may exist or have been filed covering different bicyclic compound structures, alternative synthesis methods, or specific uses of such compounds.
-
How can researchers build upon the technology described in this expired patent?
Researchers can freely use the synthetic methodology described in the patent as a starting point. They can explore variations in reaction conditions, introduce different substituents, or use the resulting bicyclic compounds as intermediates for synthesizing novel molecules, provided these new developments are not covered by other active patents.
-
What is the strategic value of expired patents like 4,507,287 for R&D?
Expired patents provide valuable insight into historical scientific advancements and serve as foundational prior art. They can inform researchers about established methods, inspire new avenues of investigation by highlighting existing knowledge, and help identify areas where new innovation is needed or possible.
-
What due diligence is required for investing in a company that utilizes bicyclic compound synthesis?
Investment due diligence should focus on the target company’s active patent portfolio, including patents on novel compounds, proprietary synthesis routes, and therapeutic applications. It must also assess trade secrets, manufacturing capabilities, market position, and freedom to operate in the current IP landscape, which extends beyond any single expired patent.
Citations
[1] Jones, G. H., & McBride, W. G. (1985). Process for preparing substituted bicyclic compounds. U.S. Patent 4,507,287. Washington, DC: U.S. Patent and Trademark Office.
More… ↓
⤷ Start Trial
|
